Brigham and Women's Hospital
Boston, Massachusetts, United States
Dr. Sparks is a rheumatologist and population scientist at Brigham and Women's Hospital and Harvard Medical School with an overall focus on using patient-oriented and epidemiologic research studies to evaluate the etiology, outcomes, and public health burden of rheumatoid arthritis (RA). In particular, he performs studies to evaluate genetic, environmental, serologic, and familial risk factors for RA, clinical trials for RA prevention, and RA outcomes research focusing on the respiratory and metabolic burden of RA. He has received research awards from the National Institutes of Health and Rheumatology Research Foundation.
Cancer Immunotherapy and Its Toxicities, Today and Tomorrow
Monday, October 27, 2025
4:00 PM – 5:00 PM Central Time
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); Amgen: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing)
Rheumatoid Arthritis-Interstitial Lung Disease (ILD)/Connective Tissue Disease/ILD
Tuesday, October 28, 2025
11:30 AM – 12:30 PM Central Time
Disclosure information not submitted.
Rheumatoid Arthritis-Interstitial Lung Disease (ILD)/Connective Tissue Disease/ILD
Tuesday, October 28, 2025
4:00 PM – 5:00 PM Central Time
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); Amgen: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing)
